Report
Damien Conover
EUR 850.00 For Business Accounts Only

Morningstar | Straumann Facing Strong Dental Market Headwinds

Straumann has made a name for itself as a global leader in the dental implant industry, consistently gaining market share from competitors through product launches, strategic acquisitions, and operational expansion. The implant market, which provides patients with a cost-effective option for single-tooth replacement, remains one of the more attractive segments of the dental industry, in our view. This market typically grows slightly faster than global GDP, thanks to increasing oral health awareness, low reimbursement risk, and an aging population. Furthermore, Straumann’s implant volume benefits from the growing number of general practitioners placing implants.While we expect these tailwinds to continue in the short term, we remain concerned about the implant industry’s longer-term shift toward lower-margin products. Straumann's growth, margins, and returns on invested capital have consistently improved after its 2012 Neodent investment, which marked its entry into the value implant market. The company’s internationalization of the Neodent value portfolio has helped Straumann steal market share from key competitors, including Dentsply Sirona and Danaher. We note that Straumann’s entry into emerging markets like China and India are primarily driven by nonpremium products. Growth of nonpremium products, which command weaker prices, should gradually dilute Straumann’s margin. Additionally, higher growth of value products, especially among general practitioners, makes the customer base less focused on product differentiation, in our view.The company’s ClearCorrect acquisition marks its orthodontic entry into the clear aligner market, which should help drive near-term growth. Straumann’s international operations and implant cross-selling opportunities create some potential with Straumann’s strategy of becoming a total solution provider in tooth correction. While we expect this segment to benefit from Align’s manufacturing patent expirations, we remain skeptical that the company can create sustainable competitive advantages in the segment, as we believe the category will become more competitive.
Underlying
Straumann Holding AG

Straumann is engaged in tooth replacement solutions that include dental implants, prosthetics and regenerative products. Co. develops, manufactures and supplies dental implants, instruments, computer-aided design/computer-aided manufacturing prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Co. provides a range of services to dental practitioners, clinics and laboratories. Through a collaboration with its academic partner the International Team for Implantology ( ITI), Co. supports research and offers training and education to dental professionals worldwide.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Damien Conover

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch